• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞病毒感染后产生的上皮细胞源性致密体的鉴定与特征分析。

Identification and Characterization of Epithelial Cell-Derived Dense Bodies Produced upon Cytomegalovirus Infection.

作者信息

García-Ríos Estéfani, Rodríguez María Josefa, Terrón María Carmen, Luque Daniel, Pérez-Romero Pilar

机构信息

National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Department of Science, Universidad Internacional de Valencia-VIU, Pintor Sorolla 21, 46002 Valencia, Spain.

出版信息

Vaccines (Basel). 2022 Aug 12;10(8):1308. doi: 10.3390/vaccines10081308.

DOI:10.3390/vaccines10081308
PMID:36016196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9412340/
Abstract

Dense bodies (DB) are complex, noninfectious particles produced during CMVinfection containing envelope and tegument proteins that may be ideal candidates as vaccines. Although DB were previously described in fibroblasts, no evidence of DB formation has been shown after propagating CMV in epithelial cells. In the present study, both fibroblast MRC-5 and epithelial ARPE-19 cells were used to study DB production during CMV infection. We demonstrate the formation of epithelial cell-derived DB, mostly located as cytoplasmic inclusions in the perinuclear area of the infected cell. DB were gradient-purified, and the nature of the viral particles was confirmed using CMV-specific immunelabeling. Epithelial cell-derived DB had higher density and more homogeneous size (200-300 nm) compared to fibroblast-derived DB (100-600 nm).In agreement with previous results characterizing DB from CMV-infected fibroblasts, the pp65 tegument protein was predominant in the epithelial cell-derived DB. Our results also suggest that epithelial cells had more CMV capsids in the cytoplasm and had spherical bodies compatible with nucleus condensation (pyknosis) in cells undergoing apoptosis that were not detected in MRC-5 infected cells at the tested time post-infection. Our results demonstrate the formation of DB in CMV-infected ARPE-19 epithelial cells that may be suitable candidate to develop a multiprotein vaccine with antigenic properties similar to that of the virions while not including the viral genome.

摘要

致密体(DB)是巨细胞病毒(CMV)感染期间产生的复杂的、非感染性颗粒,含有包膜和衣壳蛋白,可能是理想的疫苗候选物。尽管之前在成纤维细胞中描述过致密体,但在CMV在上皮细胞中增殖后,尚未有致密体形成的证据。在本研究中,成纤维细胞MRC-5和上皮细胞ARPE-19均被用于研究CMV感染期间致密体的产生。我们证明了上皮细胞来源的致密体的形成,其大多作为胞质内含物位于感染细胞的核周区域。致密体经过梯度纯化,利用CMV特异性免疫标记确认了病毒颗粒的性质。与成纤维细胞来源的致密体(100-600nm)相比,上皮细胞来源的致密体密度更高,大小更均匀(200-300nm)。与之前对CMV感染的成纤维细胞中致密体的表征结果一致,pp65衣壳蛋白在上皮细胞来源的致密体中占主导。我们的结果还表明,上皮细胞在胞质中有更多的CMV衣壳,并且在感染后测试时间点的凋亡细胞中有与核固缩(核致密)相符的球体,而在MRC-5感染细胞中未检测到。我们的结果证明了在CMV感染的ARPE-19上皮细胞中致密体的形成,其可能是开发具有与病毒体相似抗原特性但不包含病毒基因组的多蛋白疫苗的合适候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/c23f9d13acef/vaccines-10-01308-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/41b8f8336944/vaccines-10-01308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/eb60b82174f3/vaccines-10-01308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/7d585cc4029e/vaccines-10-01308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/cb698f2026d8/vaccines-10-01308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/0932ea2f7e28/vaccines-10-01308-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/cac315c8d424/vaccines-10-01308-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/c23f9d13acef/vaccines-10-01308-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/41b8f8336944/vaccines-10-01308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/eb60b82174f3/vaccines-10-01308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/7d585cc4029e/vaccines-10-01308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/cb698f2026d8/vaccines-10-01308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/0932ea2f7e28/vaccines-10-01308-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/cac315c8d424/vaccines-10-01308-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558d/9412340/c23f9d13acef/vaccines-10-01308-g007.jpg

相似文献

1
Identification and Characterization of Epithelial Cell-Derived Dense Bodies Produced upon Cytomegalovirus Infection.巨细胞病毒感染后产生的上皮细胞源性致密体的鉴定与特征分析。
Vaccines (Basel). 2022 Aug 12;10(8):1308. doi: 10.3390/vaccines10081308.
2
Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells.巨细胞病毒疫苗株 Towne 衍生的致密体诱导广泛的细胞免疫应答和中和抗体,可预防成纤维细胞和上皮细胞感染。
J Virol. 2013 Oct;87(20):11107-20. doi: 10.1128/JVI.01554-13. Epub 2013 Aug 7.
3
Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.通过可扩展生物工艺方法生产巨细胞病毒致密体可保持免疫原性并提高中和抗体滴度。
J Virol. 2016 Oct 28;90(22):10133-10144. doi: 10.1128/JVI.00463-16. Print 2016 Nov 15.
4
Selection of particles and proteins for use as human cytomegalovirus subunit vaccines.用于人巨细胞病毒亚单位疫苗的颗粒和蛋白质的选择。
Birth Defects Orig Artic Ser. 1984;20(1):305-24.
5
Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.从感染人巨细胞病毒株的细胞中释放的一种非感染性病毒样颗粒的分离与鉴定。
Virology. 1983 Oct 15;130(1):118-33. doi: 10.1016/0042-6822(83)90122-8.
6
Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells.人巨细胞病毒主要衣壳蛋白 pp65 的修饰可抑制病毒生长,并导致感染细胞中与 pUL69 和 pUL97 形成的蛋白复合物增强。
J Gen Virol. 2010 Oct;91(Pt 10):2531-41. doi: 10.1099/vir.0.022293-0. Epub 2010 Jun 30.
7
Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies.通过重组致密体将人巨细胞病毒非结构IE1蛋白的免疫显性肽外源导入MHC I类呈递途径。
J Gen Virol. 2008 Feb;89(Pt 2):369-379. doi: 10.1099/vir.0.83380-0.
8
Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.针对腺病毒 pp65 感染的树突状细胞产生的巨细胞病毒特异性细胞溶解 T 细胞系和克隆。
Biol Blood Marrow Transplant. 2001;7(5):247-56. doi: 10.1053/bbmt.2001.v7.pm11400946.
9
Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus.人巨细胞病毒病毒体、无感染性包膜颗粒和致密体的磷蛋白及蛋白激酶活性特征
J Virol. 1986 Sep;59(3):714-27. doi: 10.1128/JVI.59.3.714-727.1986.
10
Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.抗体和毒株多态性对巨细胞病毒进入及在成纤维细胞和上皮细胞中传播的影响
J Virol. 2017 Jun 9;91(13). doi: 10.1128/JVI.01650-16. Print 2017 Jul 1.

引用本文的文献

1
The battle between host antiviral innate immunity and immune evasion by cytomegalovirus.宿主抗病毒先天免疫与巨细胞病毒免疫逃逸的斗争。
Cell Mol Life Sci. 2024 Aug 9;81(1):341. doi: 10.1007/s00018-024-05369-y.
2
Subconfluent ARPE-19 Cells Display Mesenchymal Cell-State Characteristics and Behave like Fibroblasts, Rather Than Epithelial Cells, in Experimental HCMV Infection Studies.亚汇合 ARPE-19 细胞在实验性 HCMV 感染研究中表现出间充质细胞状态特征,并表现为成纤维细胞,而不是上皮细胞。
Viruses. 2023 Dec 28;16(1):49. doi: 10.3390/v16010049.

本文引用的文献

1
Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study.免疫抑制对 SARS-CoV-2 感染免疫反应的影响:一项机制研究。
Transpl Infect Dis. 2021 Dec;23(6):e13743. doi: 10.1111/tid.13743. Epub 2021 Nov 1.
2
Th17 Cells in Viral Infections-Friend or Foe?病毒感染中的 Th17 细胞:是敌是友?
Cells. 2021 May 11;10(5):1159. doi: 10.3390/cells10051159.
3
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study.2019冠状病毒病与系统性硬化症:来自意大利全国性调查研究的临床病理意义
Lancet Rheumatol. 2021 Mar;3(3):e166-e168. doi: 10.1016/S2665-9913(21)00007-2. Epub 2021 Jan 12.
4
Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV).解析适应性自然杀伤 (NK) 细胞和巨细胞病毒 (CMV) 的免疫学现象。
Int J Mol Sci. 2020 Nov 23;21(22):8864. doi: 10.3390/ijms21228864.
5
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.COVID-19 与风湿性自身免疫性系统性疾病:一项大型意大利患者系列报告。
Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27.
6
Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches.中和抗体在巨细胞病毒感染中的作用:对新治疗方法的启示
Trends Microbiol. 2020 Nov;28(11):900-912. doi: 10.1016/j.tim.2020.04.003. Epub 2020 May 21.
7
Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine.作为安全的人巨细胞病毒疫苗的五聚体阳性亚病毒致密体的生产策略。
Vaccines (Basel). 2019 Sep 1;7(3):104. doi: 10.3390/vaccines7030104.
8
Battle between Host Immune Cellular Responses and HCMV Immune Evasion.宿主免疫细胞应答与 HCMV 免疫逃逸的较量。
Int J Mol Sci. 2019 Jul 24;20(15):3626. doi: 10.3390/ijms20153626.
9
..
Vaccines (Basel). 2019 Jul 22;7(3):70. doi: 10.3390/vaccines7030070.
10
Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.gH/gL/UL128/UL130/UL131 五聚体修复的 Towne 株人巨细胞病毒致密体诱导增强的中和抗体应答。
J Virol. 2019 Aug 13;93(17). doi: 10.1128/JVI.00931-19. Print 2019 Sep 1.